AzTrials
AzTrials

Blood PressureNCT01627470

Comparison of Continuous Non-invasive Pressure Device Versus Invasive Pressure Measurement During Prehospital Emergency

An observational study of Blood Pressure, run by Robert Hanss at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate the accuracy of continuous non-invasive AP monitoring (CNAP) compared to simultaneous IBP measurement in intensive care patients undergoing a transport in the ambulance car. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Blood Pressure
What is being tested?
CNAP-Monitor
Type of treatment
Medical device
How many people
40 participants
Where
1 siteGermany
Study dates
Aug 2011to Aug 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: ICU Patients with established arterial pressure measurement

Who may be able to join

  • Patients willing and capable of giving informed consent or with legal agents willing of giving informed consent
  • Patients undergoing a transport from the intensive care unit to another institution with the ambulance car
  • Patients where the IBP cannula was already placed on the intensive care unit
  • Patients where IBP cannula, and CNAP upper arm cuff can be placed on the same arm, and CNAP finger cuff can be placed on the contra-lateral arm
  • Intact perfusion of both arm evidenced by a negative Allen's test
  • Age 18 years and above
  • ASA I-IV
  • Weight >= 40 and <= 180 kg, BMI < 35

Who cannot join

  • Patients with history of neurological, neuromuscular seizure
  • Patients where IBP cannula cannot be placed in the radial artery
  • Patients with vascular implants at the sites of non-invasive blood pressure measurement (fingers and upper arm)
  • Patients with history of arrhythmias
  • Edematous patients

Trial locations and contacts

1 site in 1 country.

Germany1 site, 1 recruiting
  • University Hospital Schleswig-Holstein - Campus Kiel

    Kiel, 24105

    Florian Reifferscheid, Dr. med., +49 431 597 2991, reifferscheid@uksh.de

    Recruiting

Other trials in Germany

About this study

Official title: Evaluation of a Continuous Non-invasive Arterial Pressure Device in Comparison With Invasive Pressure Measurement During Out-of-hospital Emergency

The aim of the study is to evaluate the accuracy of continuous non-invasive AP monitoring (CNAP) compared to simultaneous IBP measurement in intensive care patients undergoing a transport in the ambulance car.

Since CNAP finger blood pressure is calibrated to NBP level, a systematic bias between IBP and CNAP as described by a recent FDA meta analysis [ ] is expected. The most important factor of CNAP system performance is its ability to accurately track blood pressure changes. Thus, the purpose of this investigation is to show that the bias between CNAP and IBP falls within the expected range and that blood pressure alterations are detected instantaneously.

Read more

The endpoints of the study are:

  • The agreement of systolic, diastolic and mean CNAP and IBP readings determined on a beat-to-beat basis during:
  • Takeover of the patient on the intensive care unit,
  • Transport of the patient from the intensive care unit to the ambulance car
  • Transport of the patient in the ambulance car
  • The agreement of systolic, diastolic and mean CNAP and IBP blood pres-sure changes determined on a beat-to-beat basis during:
  • Takeover of the patient on the intensive care unit,
  • Transport of the patient from the intensive care unit to the ambulance car
  • Transport of the patient in the ambulance car

The beat-to-beat readings of CNAP and IBP will be automatically recorded electronically on a memory card in the transport monitor. CNAP data will additionally be recorded directly on the CNAP Monitor with a memory stick. Safety will be assessed by clinical observations as well as adverse events (AE) recording.

Read the detailed description

Arterial pressure (AP) is one of the most important physiological variables. Particularly in emergency medicine, AP needs to be monitored repeatedly or even better, continuously. This is usually done using an oscillometric pressure device (NIBP). A number of studies emphasise the importance of continuous AP monitoring as more than 20% of all hypotensive episodes may be missed by NIBP and another 20% are detected with delay. Prolonged hypotension precedes 56% of perioperative cardiac arrests and is associated with a significant increase of the 1-year mortality rate, indicating that NBP monitoring especially in patients with cardiovascular diseases might be insufficient independent from the clinical setting. Recently, a monitor for continuous non-invasive AP monitoring (CNAP™ Monitor 500) was introduced. It was shown that during procedures with high risk of hypotension NIBP missed significant more hypotensive episodes than CNAP. At the moment we have no evidence of the performance of CNAP in the preclinical emergency medicine. The evaluation against the gold standard of invasive pressure measurement in this study will help us to evaluate the performance of CNAP in the preclinical setting.

Conditions
Blood Pressure
Being tested
CNAP-Monitor
Keywords
non-invasive arterial pressure, emergency, intensive care
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CNAP-MonitorDevice

    Also called CNAP, Continuous non-invasive arterial blood pressure recording

    Continuous non-invasive arterial blood pressure recording

Study groups in NCT01627470
Study groupRoleWhat they receive
CohortEmergency Patients with applied arterial blood pressure measurement
Receives: Device: CNAP-Monitor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. agreement with invasive blood pressure

    beat-to-beat readings of CNAP and IBP

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2012 (estimated)
  2. Study startAug 2011
  3. Primary completionAug 2012 (estimated)
  4. Study completionAug 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01627470
Sponsor's protocol ID
CNAP-ITW
Status last verified
Jun 2012
First submitted
2 Nov 2011
Last updated
25 Jun 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Blood Pressure, run by Robert Hanss at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

agreement with invasive blood pressure (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in